By Justin Fein
In September, the U.S. Department of Health and Human Services (HHS) made headlines by announcing a potential association between prenatal acetaminophen use and autism spectrum disorder (ASD) or other neurodevelopmental outcomes. The statement, amplified by political figures such as Robert F. Kennedy Jr., quickly spread across mainstream news and social media – raising concerns among expectant mothers and the clinicians who care for them.
To better understand how obstetricians are processing this announcement, Konovo surveyed OB/GYN panelists about their awareness, interpretation of the evidence, impact on clinical practice, communication challenges, and general reactions. Their responses reveal a profession that is highly aware of the issue but deeply skeptical of its scientific grounding.
Awareness: Nearly Universal
When asked about their familiarity with the announcement, over 82% of OBs reported being “very familiar,” and nearly 100% reported at least some awareness. This level of engagement underscores how quickly the story spreads and how directly it touches the daily reality of obstetric practice, given acetaminophen’s long-standing role as the go-to pain and fever treatment during pregnancy.
Evidence: Skepticism Dominates
Despite high awareness, none of the OBs surveyed considered the evidence “strong.” Nearly 60% categorized it as conflicting or insufficient, while 34% considered it weak. Only 6.5% said the evidence was moderate.
This aligns with OBs’ training: interpreting evidence carefully, weighing causation versus correlation, and resisting premature conclusions. For most, science simply isn’t there yet to justify a change in practice.
Impact on Practice: Holding Steady
When asked if the announcement had changed their counseling, 84% said they do not plan to change their advice unless required by stronger guidance. Only 6.5% have already changed their recommendations, while 2% plan to do so in the future. A small group (7%) remain undecided.
The takeaway: OBs are committed to evidence-based medicine and are waiting for clear, authoritative recommendations from organizations like ACOG and SMFM before altering long-established clinical norms.
Communication Challenges: Patient Anxiety vs. Clinical Safety
Perhaps the most pressing issue for OBs is not their own interpretation of the data, but how to discuss it with patients. The top concerns included: – Patients avoiding needed pain/fever treatment (86%) – Causing unnecessary fear or anxiety (84%) – Misinformation spreading (81.5%) – Lack of clarity on what is safe (64%)
OBs are worried that the announcement could lead pregnant patients to forgo safe fever treatment – which itself carries risks for fetal development – or turn to less safe alternatives like NSAIDs. Many also flagged the additional burden of addressing misinformation during patient visits.
General Thoughts: Anger, Frustration, and Distrust
The open-ended responses were unambiguous: the vast majority of OBs expressed frustration, anger, and disbelief. Key themes included: – Distrust of political interference: Many called the announcement politically motivated, unfounded, and “fear mongering.” – Concern for patients: Clinicians stressed the harm of undermining patient trust and leaving pregnant women with fewer safe options for pain relief, “I am angered. There is no data which suggests this and it is instilling unnecessary fear in patients”
– Defense of science: OBs reiterated their reliance on evidence-based guidance, particularly from ACOG and SMFM, over political statements, “It’s horrible, not evidenced based and purely political.”
A small minority expressed openness to further study or a cautious ‘better safe than sorry’ stance, but these voices were far outweighed by those condemning the announcement as irresponsible and damaging.
Conclusion: Science, Not Politics
This survey makes one thing clear: while OBs are acutely aware of the HHS announcement, they overwhelmingly view the evidence as weak, have not changed their clinical practices, and are deeply concerned about the harm such messaging may cause. Their responses highlight a commitment to science, a defense of evidence-based medicine, and a desire to protect pregnant patients from both unnecessary fear and unnecessary risk.
At a time when medical trust is fragile, OBs are urging that decisions about maternal health be guided by rigorous science – not politics.
If you are a healthcare worker that is interested in participating in our paid research studies, please register here.
